966 related articles for article (PubMed ID: 28552348)
1. Interferon-γ Drives T
Overacre-Delgoffe AE; Chikina M; Dadey RE; Yano H; Brunazzi EA; Shayan G; Horne W; Moskovitz JM; Kolls JK; Sander C; Shuai Y; Normolle DP; Kirkwood JM; Ferris RL; Delgoffe GM; Bruno TC; Workman CJ; Vignali DAA
Cell; 2017 Jun; 169(6):1130-1141.e11. PubMed ID: 28552348
[TBL] [Abstract][Full Text] [Related]
2. A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells.
Jung K; Kim JA; Kim YJ; Lee HW; Kim CH; Haam S; Kim YS
Cancer Immunol Res; 2020 Jan; 8(1):46-56. PubMed ID: 31554638
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer.
Chuckran CA; Cillo AR; Moskovitz J; Overacre-Delgoffe A; Somasundaram AS; Shan F; Magnon GC; Kunning SR; Abecassis I; Zureikat AH; Luketich J; Pennathur A; Sembrat J; Rojas M; Merrick DT; Taylor SE; Orr B; Modugno F; Buckanovich R; Schoen RE; Kim S; Duvvuri U; Zeh H; Edwards R; Kirkwood JM; Coffman L; Ferris RL; Bruno TC; Vignali DAA
Sci Transl Med; 2021 Dec; 13(623):eabf8495. PubMed ID: 34878821
[TBL] [Abstract][Full Text] [Related]
4. Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8
Liu C; Chikina M; Deshpande R; Menk AV; Wang T; Tabib T; Brunazzi EA; Vignali KM; Sun M; Stolz DB; Lafyatis RA; Chen W; Delgoffe GM; Workman CJ; Wendell SG; Vignali DAA
Immunity; 2019 Aug; 51(2):381-397.e6. PubMed ID: 31350177
[TBL] [Abstract][Full Text] [Related]
5. Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis.
Delgoffe GM; Woo SR; Turnis ME; Gravano DM; Guy C; Overacre AE; Bettini ML; Vogel P; Finkelstein D; Bonnevier J; Workman CJ; Vignali DA
Nature; 2013 Sep; 501(7466):252-6. PubMed ID: 23913274
[TBL] [Abstract][Full Text] [Related]
6. Cancer Exacerbates Ischemic Brain Injury Via Nrp1 (Neuropilin 1)-Mediated Accumulation of Regulatory T Cells Within the Tumor.
Wang L; Zhou Y; Yin J; Gan Y; Wang X; Wen D; Thomson AW; Hu X; Yang L; Stetler RA; Li P; Yu W
Stroke; 2018 Nov; 49(11):2733-2742. PubMed ID: 30355201
[TBL] [Abstract][Full Text] [Related]
7. Protection of Regulatory T Cells from Fragility and Inactivation in the Tumor Microenvironment.
Zhang H; Tomar VS; Li J; Basavaraja R; Yan F; Gui J; McBrearty N; Costich TL; Beiting DP; Blanco MA; Conejo-Garcia JR; Saggu G; Berger A; Nefedova Y; Gabrilovich DI; Fuchs SY
Cancer Immunol Res; 2022 Dec; 10(12):1490-1505. PubMed ID: 36255418
[TBL] [Abstract][Full Text] [Related]
8. CD4+Foxp3+T Regulatory Cells Promote Transplantation Tolerance by Modulating Effector CD4+ T Cells in a Neuropilin-1-Dependent Manner.
Campos-Mora M; Contreras-Kallens P; Gálvez-Jirón F; Rojas M; Rojas C; Refisch A; Cerda O; Pino-Lagos K
Front Immunol; 2019; 10():882. PubMed ID: 31068948
[TBL] [Abstract][Full Text] [Related]
9. Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis.
Wen YH; Lin HQ; Li H; Zhao Y; Lui VWY; Chen L; Wu XM; Sun W; Wen WP
Cancer Immunol Immunother; 2019 Feb; 68(2):221-232. PubMed ID: 30357458
[TBL] [Abstract][Full Text] [Related]
10. Treg Fragility: A Prerequisite for Effective Antitumor Immunity?
Overacre-Delgoffe AE; Vignali DAA
Cancer Immunol Res; 2018 Aug; 6(8):882-887. PubMed ID: 30068755
[TBL] [Abstract][Full Text] [Related]
11. STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer.
Oweida AJ; Darragh L; Phan A; Binder D; Bhatia S; Mueller A; Court BV; Milner D; Raben D; Woessner R; Heasley L; Nemenoff R; Clambey E; Karam SD
J Natl Cancer Inst; 2019 Dec; 111(12):1339-1349. PubMed ID: 30863843
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral depletion of regulatory T cells using CD25-targeted photodynamic therapy in a mouse melanoma model induces antitumoral immune responses.
Oh DS; Kim H; Oh JE; Jung HE; Lee YS; Park JH; Lee HK
Oncotarget; 2017 Jul; 8(29):47440-47453. PubMed ID: 28537894
[TBL] [Abstract][Full Text] [Related]
13. Comparative transcriptome analysis reveals distinct genetic modules associated with Helios expression in intratumoral regulatory T cells.
Yates K; Bi K; Haining WN; Cantor H; Kim HJ
Proc Natl Acad Sci U S A; 2018 Feb; 115(9):2162-2167. PubMed ID: 29440380
[TBL] [Abstract][Full Text] [Related]
14. Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy.
Chuckran CA; Liu C; Bruno TC; Workman CJ; Vignali DA
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32675311
[TBL] [Abstract][Full Text] [Related]
15. Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFNγ-Dependent Tumor Vessel Regression.
Kurebayashi Y; Olkowski CP; Lane KC; Vasalatiy OV; Xu BC; Okada R; Furusawa A; Choyke PL; Kobayashi H; Sato N
Cancer Res; 2021 Jun; 81(11):3092-3104. PubMed ID: 33574087
[TBL] [Abstract][Full Text] [Related]
16. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
[TBL] [Abstract][Full Text] [Related]
17. Requirement of Treg-intrinsic CTLA4/PKCη signaling pathway for suppressing tumor immunity.
Pedros C; Canonigo-Balancio AJ; Kong KF; Altman A
JCI Insight; 2017 Dec; 2(23):. PubMed ID: 29212947
[TBL] [Abstract][Full Text] [Related]
18. INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts.
Yu Y; Huang R; Zong X; He X; Mo W
BMC Cancer; 2016 Jul; 16():397. PubMed ID: 27389040
[TBL] [Abstract][Full Text] [Related]
19. Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.
Klages K; Mayer CT; Lahl K; Loddenkemper C; Teng MW; Ngiow SF; Smyth MJ; Hamann A; Huehn J; Sparwasser T
Cancer Res; 2010 Oct; 70(20):7788-99. PubMed ID: 20924102
[TBL] [Abstract][Full Text] [Related]
20. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.
Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V
J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
